Cross-species liver cell growth could represent a solution to transplant shortage

FHS
May 9, 2024
3:24 am

Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.

Biotest increases sales in the first half of 2024 by 35% to Euro 372 million – Biotech Investments

EQS-News: Biotest AG / Key word(s): Half Year Report Biotest increases sales in the first half of 2024 by 35% to Euro 372 million 06.08.2024

August 7, 2024

Pharmalittle: We’re reading about a Senate probe into Novo pricing, a new UTI antibiotic, and more

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of

April 25, 2024

Pharma is betting big on connecting potential patients to its medications. It’s just the beginning

Pharma companies are getting more serious about telehealth. In the past three months, Eli Lilly launched a splashy website connecting consumers with places to get

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.